Collegium Pharmaceutical
COLL
COLL
145 hedge funds and large institutions have $476M invested in Collegium Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+25
Holders Change %
+20.83%
% of All Funds
3.14%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
42
Increased
36
Reduced
43
Closed
17
Calls
$395K
Puts
$197K
Net Calls
+$198K
Net Calls Change
-$678K
Top Buyers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
+$5.98M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.92M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.87M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.07M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.07M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$18.7M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$12.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$7.9M |
| 4 |
PA
Perceptive Advisors
New York
|
-$7.37M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.26M |
